Mortality patterns among hypertensives by reported level of caffeine consumption

Area of Science:

• Cardiovascular epidemiology
• Public health research
• Dietary impact on health

Background:

• Hypertension is a significant risk factor for cardiovascular disease and mortality.
• Caffeine is a widely consumed stimulant with potential health implications.
• Understanding the interplay between caffeine intake, hypertension, and mortality is crucial for public health guidance.

Purpose of the Study:

• To investigate the association between caffeine consumption and all-cause and cardiovascular disease mortality in a cohort of hypertensive individuals.
• To examine whether cigarette smoking modifies the relationship between caffeine intake and mortality outcomes.

Main Methods:

• A historical cohort study design was employed, analyzing data from 10,064 hypertensive individuals.
• Caffeine intake was estimated from beverages (coffee, tea) and medications at a 1-year follow-up visit.
• Mortality outcomes (all-cause and cardiovascular) were assessed over a subsequent 4-year period.

Main Results:

• No significant association was found between higher caffeine consumption levels and increased all-cause or cardiovascular disease mortality.
• Cigarette smoking demonstrated a significant association with increased mortality.
• The mortality risk associated with smoking was more pronounced in individuals with non- or low-caffeine intake.

Conclusions:

• Caffeine consumption does not appear to elevate mortality risk in diagnosed hypertensive individuals.
• Cigarette smoking poses a substantial mortality risk, particularly for those with limited caffeine intake.
• Public health messaging should emphasize smoking cessation, especially for hypertensive individuals with low caffeine consumption.